Suchen Sie nach Informationen zu Editas Medizinzentrale? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.editasmedicine.com/
At Editas Medicine, we are using this technology to develop transformative and durable medicines for people living with serious diseases. We are motivated to deliver transformative medicines to the greatest number of patients around the world. Learn more about our commitment.
https://www.editasmedicine.com/about/
Editas Medicine is a leading genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.
https://www.editasmedicine.com/careers/
At Editas Medicine, we know that our greatest strength comes from the people who make up our team. Each employee brings diverse perspectives, backgrounds, and thinking styles, and, by embracing and celebrating these differences, we strengthen our Inspiritas culture and further our mission to pioneer a new field of genome editing.
https://www.editasmedicine.com/newsroom/
Editas Medicine is a leading gene editing company dedicated to developing gene edited medicines for people living with serious diseases around the world. Check out our press releases and other company information to stay apprised of …
https://ir.editasmedicine.com/news-releases/news-release-details/editas-medicine-announces-first-quarter-2022-results-and
As a leading genome editing company, Editas Medicineis focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world.
https://ir.editasmedicine.com/investor-relations
Editas Medicine Appoints Baisong Mei, M.D., Ph.D., as Chief Medical Officer June 7, 2022 Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and …
https://ir.editasmedicine.com/events-and-presentations
May 2022 Corporate Presentation. April 2022 Corporate Effectiveness Presentation. Past Events. Q1 2022 Editas Medicine Inc. Earnings Conference Call. May 4, 2022 at 8:00 AM EDT. Click here for Webcast. Cowen 42nd Annual Healthcare Conference. Mar 8, …
https://ir.editasmedicine.com/news-releases/news-release-details/clinical-data-editas-medicines-ongoing-phase-12-brilliance
CAMBRIDGE, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that an abstract featuring initial clinical data from the BRILLIANCE clinical trial of EDIT-101 has been selected for an oral presentation at the 2021 European Society of Gene and Cell Therapy (ESGCT) Annual Congress …
https://www.globenewswire.com/news-release/2022/07/20/2483196/0/en/Editas-Medicine-Reports-Inducement-Grant-to-New-Chief-Medical-Officer.html
The stock option provides for the purchase of up to 171,602 shares of Editas Medicine common stock at a price of $14.99 per share, the closing price per share of Editas Medicine common stock as ...
https://www.bizjournals.com/boston/news/2022/07/21/editas-new-cmo-verve-public-offering-petri-dish.html
The appointment comes about five months after Editas quietly fired its last chief medical officer, Lisa Michaels. Michaels was only with the …
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Editas Medizinzentrale gefunden haben.
